Bio-Techne Q2 Results Miss Estimates; Declares Dividend
(RTTNews) - Life sciences company Bio-Techne Corp. (TECH) reported Thursday that second-quarter net earnings attributable to the company almost halved to $27.47 million or $0.17 per share from $50.01 million or $0.31 per share in the prior-year quarter.
Excluding items, adjusted earnings were $0.40 per share, compared to $0.47 per share in the year-ago quarter.
Net sales for the quarter edged up to $272.60 million from last year's $271.58 million. Organic revenue decreased 2 percent.
On average, 12 analysts polled by Thomson Reuters expected the company to report earnings of $0.41 per share on revenues of $277.53 million for the quarter. Analysts' estimates typically exclude special items.
Separately, Bio-Techne 's Board of Directors decided to pay a dividend of $0.08 per share for the quarter ended December 31, 2023, payable on February 26, 2024, to all common shareholders of record on February 12, 2024.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Bio-Techne Files Drug Master File With FDA For ExCellerate GMP IPSC Expansion Medium
Bio-Techne Promotes Kim Kelderman To Succeed Chuck Kummeth As President And CEO
Bio-Techne, Akoya To End Co-development Of RNAscope For Use With PhenoCycler-Fusion System
Bio-Techne To Acquire Namocell For Undisclosed Terms
Canadian Dollar Falls Against Most Majors
Swiss Market Ends Modestly Higher As Stocks Rise In The Final Hour
European Markets Close Higher As Stocks Recover After Cautious Start
